ebook Munafa Stock Market Course + Intraday & FNO calls  

       

AkebiaTherapeutics AKBA full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI

Akebia Therapeutics AKBA WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NASDAQ stock exchange

operates under Health Care sector & deals in Major Pharmaceuticals

Daily price and charts and targets AkebiaTherapeutics

Strong intraday Stock price targets for AkebiaTherapeutics are 1.41 and 1.46

Intraday Target 11.37
Intraday Target 21.4
Intraday Target 31.42
Intraday Target 41.45
Intraday Target 51.47

Daily price and volume Akebia Therapeutics

Date Closing Open Range Volume
Thu 23 April 2026 1.43 (0.7%) 1.43 1.39 - 1.44 0.8902 times
Wed 22 April 2026 1.42 (0.71%) 1.42 1.40 - 1.45 0.6126 times
Tue 21 April 2026 1.41 (-1.4%) 1.45 1.40 - 1.46 0.7564 times
Mon 20 April 2026 1.43 (1.42%) 1.41 1.40 - 1.45 0.8094 times
Fri 17 April 2026 1.41 (3.68%) 1.38 1.33 - 1.45 1.676 times
Thu 16 April 2026 1.36 (-12.26%) 1.54 1.35 - 1.56 2.0655 times
Wed 15 April 2026 1.55 (-0.64%) 1.57 1.53 - 1.60 0.8592 times
Tue 14 April 2026 1.56 (6.12%) 1.47 1.47 - 1.56 0.7747 times
Mon 13 April 2026 1.47 (5%) 1.40 1.39 - 1.47 0.7138 times
Fri 10 April 2026 1.40 (-0.71%) 1.41 1.38 - 1.46 0.8421 times
Thu 09 April 2026 1.41 (-1.4%) 1.42 1.41 - 1.45 0.5257 times

 Daily chart AkebiaTherapeutics

Weekly price and charts AkebiaTherapeutics

Strong weekly Stock price targets for AkebiaTherapeutics AKBA are 1.41 and 1.48

Weekly Target 11.36
Weekly Target 21.39
Weekly Target 31.4266666666667
Weekly Target 41.46
Weekly Target 51.5

Weekly price and volumes for Akebia Therapeutics

Date Closing Open Range Volume
Thu 23 April 2026 1.43 (1.42%) 1.41 1.39 - 1.46 0.6251 times
Fri 17 April 2026 1.41 (0.71%) 1.40 1.33 - 1.60 1.2403 times
Fri 10 April 2026 1.40 (1.45%) 1.37 1.30 - 1.47 0.8841 times
Thu 02 April 2026 1.38 (2.99%) 1.34 1.30 - 1.46 0.6916 times
Fri 27 March 2026 1.34 (-4.96%) 1.43 1.32 - 1.45 0.8943 times
Fri 20 March 2026 1.41 (-3.42%) 1.48 1.39 - 1.56 0.7572 times
Fri 13 March 2026 1.46 (14.06%) 1.26 1.25 - 1.52 1.1598 times
Fri 06 March 2026 1.28 (-2.29%) 1.27 1.18 - 1.30 1.1406 times
Fri 27 February 2026 1.31 (11.02%) 1.19 1.18 - 1.51 1.6635 times
Fri 20 February 2026 1.18 (-2.48%) 1.21 1.14 - 1.24 0.9434 times
Fri 13 February 2026 1.21 (0%) 1.35 1.20 - 1.37 0.5045 times

 weekly chart AkebiaTherapeutics

Monthly price and charts AkebiaTherapeutics

Strong monthly Stock price targets for AkebiaTherapeutics AKBA are 1.37 and 1.67

Monthly Target 11.14
Monthly Target 21.29
Monthly Target 31.4433333333333
Monthly Target 41.59
Monthly Target 51.74

Monthly price and volumes Akebia Therapeutics

Date Closing Open Range Volume
Thu 23 April 2026 1.43 (2.88%) 1.40 1.30 - 1.60 0.5142 times
Tue 31 March 2026 1.39 (6.11%) 1.27 1.18 - 1.56 0.7275 times
Fri 27 February 2026 1.31 (-7.75%) 1.39 1.14 - 1.60 1.1439 times
Fri 30 January 2026 1.42 (-11.8%) 1.63 1.30 - 1.63 0.773 times
Wed 31 December 2025 1.61 (1.9%) 1.60 1.45 - 1.73 0.8787 times
Fri 28 November 2025 1.58 (-28.51%) 2.10 1.49 - 2.15 1.2547 times
Fri 31 October 2025 2.21 (-19.05%) 2.72 2.07 - 3.20 1.428 times
Tue 30 September 2025 2.73 (-13.06%) 3.07 2.66 - 3.22 1.0385 times
Fri 29 August 2025 3.14 (-14.91%) 3.65 2.92 - 3.79 1.2409 times
Thu 31 July 2025 3.69 (1.37%) 3.63 3.47 - 4.08 1.0005 times
Mon 30 June 2025 3.64 (20.13%) 3.06 2.97 - 4.08 1.7478 times

 monthly chart AkebiaTherapeutics

Yearly price and charts AkebiaTherapeutics

Strong yearly Stock price targets for AkebiaTherapeutics AKBA are 1.04 and 1.53

Yearly Target 10.91
Yearly Target 21.17
Yearly Target 31.4
Yearly Target 41.66
Yearly Target 51.89

Yearly price and volumes Akebia Therapeutics

Date Closing Open Range Volume
Thu 23 April 2026 1.43 (-11.18%) 1.63 1.14 - 1.63 0.3415 times
Wed 31 December 2025 1.61 (-15.26%) 1.90 1.45 - 4.08 1.5251 times
Tue 31 December 2024 1.90 (53.23%) 1.22 0.80 - 2.48 1.1354 times
Fri 29 December 2023 1.24 (117.54%) 0.58 0.49 - 1.84 0.6873 times
Fri 30 December 2022 0.57 (-74.78%) 2.28 0.24 - 2.93 2.5606 times
Fri 31 December 2021 2.26 (-19.29%) 2.83 2.20 - 5.14 1.5332 times
Thu 31 December 2020 2.80 (-55.7%) 6.38 2.09 - 13.71 1.4104 times
Tue 31 December 2019 6.32 (14.29%) 5.40 2.99 - 9.30 0.415 times
Mon 31 December 2018 5.53 (-63.5%) 14.98 5.20 - 15.83 0.2041 times
Wed 27 December 2017 15.15 (45.53%) 10.66 8.58 - 20.25 0.1872 times
Fri 30 December 2016 10.41 (0%) 8.05 7.00 - 11.07 0.0774 times

Indicator Analysis of AkebiaTherapeutics

Tomorrow's movement Prediction of Akebia Therapeutics AKBA appears to be in uptrend. But this trend seems to be weakening.

Price is below an important level of 1.43 on charts, and if price remains below this level, then stock might show a fall in short term.

Tomorrow's movement Prediction of Akebia Therapeutics AKBA made a big move recently. This generally happens when there is a positive sentiment change, or a block deal went through. There is a good chance that this trend might continue in coming days.

Munafa value: 55 as on Thu 23 April 2026

This Munafa value indicates that the stock is moving sideways and there is no definite momentum in the stock.

SMA20 is at 2 and price is deviating by 1 points

Upper Bollinger band is at 2 and lower is at 2, while middle bands are at 2 and 2

Price is rising

Price is above 20day SMA

Price is in lower range of bands

Price action analysis of AkebiaTherapeutics (AKBA) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small

ADX buy sell signal for AkebiaTherapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for AkebiaTherapeutics in short term and the buy signal is strong.

AkebiaTherapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.

Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up

CCI has generated a SELL signal for AkebiaTherapeutics in short term and SELL signal is strong!

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in positive zone. This is a BUY zone

Stock of AkebiaTherapeutics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 1.43 and AkebiaTherapeutics AKBA stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the AkebiaTherapeutics AKBA stock. Volume based technical analysis of AkebiaTherapeutics AKBA stock is negative.

AkebiaTherapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

DMA SMA EMA moving averages of Akebia Therapeutics AKBA

DMA (daily moving average) of Akebia Therapeutics AKBA

DMA period DMA value
5 day DMA 1.42
12 day DMA 1.44
20 day DMA 1.41
35 day DMA 1.4
50 day DMA 1.36
100 day DMA 1.43
150 day DMA 1.77
200 day DMA 2.17

EMA (exponential moving average) of Akebia Therapeutics AKBA

EMA period EMA current EMA prev EMA prev2
5 day EMA1.431.431.43
12 day EMA1.431.431.43
20 day EMA1.411.411.41
35 day EMA1.371.371.37
50 day EMA1.361.361.36

SMA (simple moving average) of Akebia Therapeutics AKBA

SMA period SMA current SMA prev SMA prev2
5 day SMA1.421.411.43
12 day SMA1.441.441.43
20 day SMA1.411.411.41
35 day SMA1.41.391.39
50 day SMA1.361.361.36
100 day SMA1.431.441.44
150 day SMA1.771.781.79
200 day SMA2.172.182.2

Videos related to: AkebiaTherapeutics AKBA full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI

Hindi Video What Is Needed To Succeed In Stock Markets

AkebiaTherapeutics AKBA full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI

 

Back to top